跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 270 条关于
“AASLD”
全部
270
临床试验
153
药物
0
机构
0
资讯
117
10个月前
GENFIT Showcases ACLF Pipeline Advances at AASLD 2025 with Three Novel Therapeutic Programs
去年
Sagimet's Denifanstat Shows Significant Anti-Fibrotic Benefits in Advanced MASH Patients at AASLD 2025
11个月前
Vir Biotechnology to Present 48-Week SOLSTICE Trial Results for Hepatitis Delta Combination Therapy at AASLD 2025
11个月前
Rivus Pharmaceuticals to Present Phase 2a MASH Trial Data for Novel Metabolic Accelerator HU6 at AASLD 2025
去年
Gilead Presents New Liver Disease Research at AASLD 2024
去年
Vir Biotechnology Advances Hepatitis Programs and Oncology Pipeline with Sanofi Deal
去年
Vir Biotechnology Advances Hepatitis and Oncology Programs, Announces Q3 2024 Results
去年
Target RWE Showcases Groundbreaking Liver Disease Research at EASL Congress 2025
去年
Type 2 Diabetes Significantly Increases Risk of MASH Progression to Cirrhosis, New Target RWE Study Reveals
10个月前
Exact Sciences' Blood Test Shows Seven-Fold Improvement in Early Liver Cancer Detection Over Standard Ultrasound
第 1 页,共 12 页
上一页
下一页